Full Text View
Tabular View
No Study Results Posted
Related Studies
Immune Response & Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccine
This study has been completed.
Study NCT00148941   Information provided by GlaxoSmithKline
First Received: September 7, 2005   Last Updated: October 9, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prophylaxis
Diphtheria
Tetanus
Pertussis
Poliomyelitis
Additional conditions recognized in this trial
Whooping Cough
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Bordetella Infections
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Clostridium Infections
Corynebacterium Infections
Enterovirus Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Infection
Motor Neuron Disease
Myelitis
Nervous System Diseases
Neuromuscular Diseases
Picornaviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Spinal Cord Diseases
Virus Diseases
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services